COMMUNIQUÉS West-GlobeNewswire

Herantis Pharma's Lymfactin study advances to last patient cohort, company announces initial plans for continued development
22/06/2017
Herantis Pharma's Lymfactin study advances to last patient cohort, company announces initial plans for continued development Herantis Pharma Plc Company release 22 June 2017 at 9:00 am Herantis Pharma Plc's ("Herantis [...]
Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack
22/06/2017
Phase III CANTOS study met the primary endpoint, a composite of heart attack, stroke and cardiovascular death, showing that ACZ885 (canakinumab) in combination with standard of care therapy reduces cardiovascular risk [...]
Santhera's Raxone® Receives First Positive EAMS Scientific Opinion from UK's MHRA in Duchenne Muscular Dystrophy
22/06/2017
Liestal, Switzerland, June 22, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted Raxone (idebenone) a positive scientific opinion [...]
HalioDx receives CLIA Compliance for Immunoscore® Colon
21/06/2017
HalioDx receives CLIA Compliance for Immunoscore® Colon HalioDx received CMS [1] CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a [...]
Mithra Pharmaceuticals: MITHRA SUCCESSFULLY RAISES €26.1 MILLION
21/06/2017
NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL PRESS RELEASE REGULATED INFORMATION - INSIDE [...]
Amer Sports half-year 2017 financial report published on July 27
21/06/2017
Amer Sports Corporation STOCK EXCHANGE RELEASE June 21, 2017 at 2:15 p.m. Amer Sports half-year 2017 financial report published on July 27 Amer Sports Corporation will publish its half-year financial report 2017 on [...]
Hemcheck Sweden AB: Presents results from user tests at Karlstad Central Hospital
21/06/2017
Hemcheck Sweden AB (publ) presents results from user tests at Karlstad Central Hospital hemCheck, a medical technology company addressing the issue of hemolysis, announces results from user tests at Karlstad Central [...]
A study of elite athletes shows that ColdZyme provides protection as evidenced by fewer sick days and lost training days, as well as improved quality of life
21/06/2017
News Enzymatica Study Elite Athletes Eng 170621 This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they [...]
Mithra Pharmaceuticals: MITHRA LAUNCHES A CAPITAL INCREASE BY MEANS OF A PRIVATE PLACEMENT VIA AN ACCELERATED BOOKBUILD OFFERING
21/06/2017
NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL PRESS RELEASE REGULATED INFORMATION - INSIDE [...]
Novartis achieves important regulatory milestone for AMG 334 (erenumab) in migraine prevention with EMA filing acceptance
21/06/2017
AMG 334 (erenumab) is the first anti-CGRP monoclonal antibody developed for migraine prevention to receive EMA regulatory filing acceptance Filing is supported by a comprehensive clinical program of over 2,600 migraine [...]
MITHRA COMPLETES RECRUITMENT FOR ADDITIONAL ESTELLE® SAFETY STUDY
21/06/2017
PRESS RELEASE MITHRA COMPLETES RECRUITMENT FOR ADDITIONAL estelle® SAFETY studY Safety study is part of the development of Estelle®, Mithra's combined oral contraceptive candidate Aim of the study is to analyze a broad [...]
Novo Nordisk receives positive 17-2 vote from FDA Advisory Committee that Victoza® provides substantial evidence of cardiovascular risk reduction in patients with type 2 diabetes
20/06/2017
Bagsværd, Denmark, 20 June 2017 - Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) has completed its meeting regarding the [...]
Galapagos increases share capital through warrant exercises
20/06/2017
Mechelen, Belgium; 20 June 2017, 22.00 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 52,030 new ordinary [...]
Oriola Corporation starts repurchase of its own class B shares in connection with the company's incentive schemes
20/06/2017
Oriola Corporation Stock Exchange Release 20 June 2017 18.00 Oriola Corporation starts repurchase of its own class B shares in connection with the company's incentive schemes The Board of Directors of Oriola Corporation [...]
New Data Reveal Medtronic CRT Devices Improve Therapy Delivery and Reduce Healthcare Costs
20/06/2017
Data Presented at EUROPACE 2017 Reinforce Cost and Outcome Benefits of Exclusive EffectivCRT(TM) and AdaptivCRT(TM) Algorithms, Along with Improved Device Longevity DUBLIN and VIENNA - June 20, 2017 - Medtronic plc ( [...]
The Jackson Laboratory and Crown Bioscience Announce Global Pre-Clinical Research Agreement
20/06/2017
BAR HARBOR, Maine and SANTA CLARA, Calif., June 20, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience (CrownBio), a wholly owned subsidiary of Crown Bioscience International (TWSE: ticker 6554), and The Jackson Laboratory (JAX [...]
Holaira Announces Company Name Change to Nuvaira
20/06/2017
Company Adds Shane Gleason to Executive Team MINNEAPOLIS, June 20, 2017 (GLOBE NEWSWIRE) -- Holaira , a developer of medical devices to treat obstructive lung diseases, today announced that it has changed its name to [...]
The Jackson Laboratory et Crown Bioscience annoncent un accord mondial de recherche préclinique
20/06/2017
BAR HARBOUR (Maine) et SANTA CLARA (Californie), le 20 juin 2017 (GLOBE NEWSWIRE) - Crown Bioscience (CrownBio), filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et The [...]
Holaira annonce le changement de dénomination de la société pour devenir Nuvaira
20/06/2017
Shane Gleason joint l'équipe de direction de la société MINNEAPOLIS, le 20 juin 2017 (GLOBE NEWSWIRE) - Holaira , développeur de dispositifs médicaux destinés à traiter les maladies pulmonaires obstructives, a annoncé [...]

Pages